top of page
  • White Facebook Icon
  • White Twitter Icon
Search

M&A Transaction

  • Aug 7, 2024
  • 1 min read

Updated: Sep 19, 2024

Scope Law acts as Swiss legal counsel to the shareholders of Pharma-Data S.A. (Greece) on its sale to Rosemont Pharmaceuticals Ltd. (United Kingdom).


Pharma-Data specialises in Research and Development and development of Value-Added Medicinal Drug Products for Europe and USA. Rosemont is a leading developer, manufacturer and distributor of liquid medicines for over 50 years.


The acquisition complements Rosemont’s product development capability in house as well as improving Rosemont’s capability to develop other dosage forms and modified release oral liquids.


 
 
 

Recent Posts

See All
Ranking

For the fifth consecutive year, Scope Law has been ranked as one of the top Swiss law firms by the renowned business magazines BILANZ and PME. We are very pleased to be included in the ranking again.

 
 
 
Financing Round

Scope Law advises Amenti AG in another successfully closed seven-digit financing round. Amenti is an innovative real estate technology (PropTech) startup, incorporated in Zurich in 2018 with the aim o

 
 
 
Financing Round

Scope Law advised CMT Digital , a US-based early-stage web3 venture firm, as lead investor in the USD 30 million strategic funding round of STS Digital AG , Zug, Switzerland, the holding company of a

 
 
 

Comments

bottom of page